(Q35875929)

10 August 2017

1 reference

title

The changing face of antibiotic prescribing: the mutant selection window (English)

1 reference

10 August 2017

0 references

Benjamin J Epstein

1

1 reference

10 August 2017

John G Gums

series ordinal

2

1 reference

10 August 2017

Karl Drlica

series ordinal

3

1 reference

10 August 2017

language of work or name

English

0 references

publication date

31 August 2004

1 reference

Annals of Pharmacotherapy

10 August 2017

published in

1 reference

10 August 2017

volume

38

1 reference

10 August 2017

issue

10

1 reference

10 August 2017

page(s)

1675-1682

1 reference

Multidrug resistance--a sign of the times.

10 August 2017

cites work

1 reference

Influence of population density on antibiotic resistance

21 January 2018

1 reference

Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: results from the TRUST Surveillance Program, 1999-2000.

21 January 2018

1 reference

Emergence of Multiply Resistant Pneumococci

21 January 2018

1 reference

Antimicrobial-drug resistance

21 January 2018

1 reference

Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene

21 January 2018

1 reference

Increasing antimicrobial resistance in gram-negative bacilli isolated from patients in intensive care units

21 January 2018

1 reference

Antimicrobial activity of broad-spectrum agents tested against Gram-negative bacilli resistant to ceftazidime: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).

21 January 2018

1 reference

Characterization of Pseudomonas aeruginosa isolates: occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY Antimicrobial Surveillance Program, 1997-1999.

21 January 2018

1 reference

Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group

21 January 2018

1 reference

Patients' interviews and misuse of antibiotics

21 January 2018

1 reference

Antibiotic resistance--squeezing the balloon?

21 January 2018

1 reference

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

21 January 2018

1 reference

Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinolone studies

21 January 2018

1 reference

Mutant prevention concentration as a measure of antibiotic potency: studies with clinical isolates of Mycobacterium tuberculosis

21 January 2018

1 reference

Restricting the selection of antibiotic-resistant mutant bacteria: measurement and potential use of the mutant selection window

21 January 2018

1 reference

In vitro pharmacodynamic evaluation of the mutant selection window hypothesis using four fluoroquinolones against Staphylococcus aureus.

21 January 2018

1 reference

Emergence of resistant Streptococcus pneumoniae in an in vitro dynamic model that simulates moxifloxacin concentrations inside and outside the mutant selection window: related changes in susceptibility, resistance frequency and bacterial killing

21 January 2018

1 reference

Mutant prevention concentration of nalidixic acid, ciprofloxacin, clinafloxacin, levofloxacin, norfloxacin, ofloxacin, sparfloxacin or trovafloxacin for Escherichia coli under different growth conditions

21 January 2018

1 reference

Mutant prevention concentrations of fluoroquinolones for clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

The importance of pharmacokinetic/pharmacodynamic surrogate markers to outcome. Focus on antibacterial agents

21 January 2018

1 reference

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 January 2018

1 reference

Pharmacodynamics of levofloxacin: a new paradigm for early clinical trials

21 January 2018

1 reference

Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients

21 January 2018

1 reference

Fluoroquinolone resistance is a poor surrogate marker for type II topoisomerase mutations in clinical isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

Drug resistance in mycobacteria

21 January 2018

1 reference

Concentrations of bacteria in cerebrospinal fluid of patients with bacterial meningitis

21 January 2018

1 reference

Concentration-dependent selection of small phenotypic differences in TEM beta-lactamase-mediated antibiotic resistance

21 January 2018

1 reference

Mutant prevention concentration of garenoxacin (BMS-284756) for ciprofloxacin-susceptible or -resistant Staphylococcus aureus.

21 January 2018

1 reference

Mutant prevention concentration as a measure of fluoroquinolone potency against mycobacteria

21 January 2018

1 reference

Selection of Streptococcus pneumoniae mutants having reduced susceptibility to moxifloxacin and levofloxacin.

21 January 2018

1 reference

Effect of chloramphenicol, erythromycin, moxifloxacin, penicillin and tetracycline concentration on the recovery of resistant mutants of Mycobacterium smegmatis and Staphylococcus aureus

21 January 2018

1 reference

Mutant prevention concentration of gemifloxacin for clinical isolates of Streptococcus pneumoniae

21 January 2018

1 reference

In vitro selective antibiotic concentrations of beta-lactams for penicillin-resistant Streptococcus pneumoniae populations

21 January 2018

1 reference

The mutant selection window and antimicrobial resistance

21 January 2018

1 reference

Noncompliance with directly observed therapy for tuberculosis. Epidemiology and effect on the outcome of treatment

21 January 2018

1 reference

Stretching the mutant prevention concentration (MPC) beyond its limits

21 January 2018

1 reference

Application of a mathematical model to prevent in vivo amplification of antibiotic-resistant bacterial populations during therapy

21 January 2018

1 reference

Mutant selection window in levofloxacin and moxifloxacin treatments of experimental pneumococcal pneumonia in a rabbit model of human therapy.

21 January 2018

1 reference

Effect of low-level resistance on subsequent enrichment of fluoroquinolone-resistant Streptococcus pneumoniae in rabbits.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1E041

1 reference

10 August 2017

1 reference